Nuvaprin HD By Purity Products Overview & Drug Interactions

Check For Interactions With Nuvaprin HD

Supplement: Nuvaprin HD by Purity Products

Nuvaprin HD Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Nuvaprin HD by Purity Products

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Vegetarian Capsule(s)
Maximum serving Sizes:
2 Vegetarian Capsule(s)
Servings per container 30

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Diosmin
450 mg
Diosmin --
Horse Chestnut extract
250 mg
Horse Chestnut --
Aescin
50 mg
Aescin
Hesperidin
50 mg
Hesperidin --

Other Ingredients:
Hypromellose
Microcrystalline Cellulose
Stearic Acid
Silica


Label Statments:


General Statements
- Intelligent nutritional solutions
- Premium grade supplements Since 1993
Formula
- Hesperidin and diosmin complex
Formulation
- Promotes healthy vein appearance Supports vein function and integrity
FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Suggested Use: Adults take 2 capsules daily. Optimally, for the first 15 days, take two servings daily. For daily use.
Brand IP Statement(s)
- DiosVein is a registered trademark of Exquim S.A.

Brand Information

See all products by this brand

Manufacturer
Name Purity Products

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.